eHealth Study for Chronic Pain in Black and LGBTQ+ Adults
This study is testing an app called EPIO, which is a program designed to help you manage chronic pain using cognitive-behavioral techniques. The goal is to see how well this app can be shared and used by Black and/or LGBTQ+ adults in the USA who have had chronic pain for at least three months, and whose pain makes daily activities difficult. You would need daily access to a smartphone or tablet and be willing to use the EPIO app. Researchers will measure changes in your pain experience using a score called the West Haven Yale Multiphasic Pain Inventory (WHYMPI) at the beginning and after 6 weeks. The current status of this study is unclear, and it plans to enroll 300 people.
- Study design
- This is an interventional study, meaning you will receive a specific intervention. It plans to enroll 300 participants.
- What's involved
- Participants will receive access to the EPIO app for 3 months. Your pain will be measured at the start and after 6 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain will be measured at baseline and at 6 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Under-Resourced Adults With Chronic Pain eHealth Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Eleshia J. Morrison, Ph.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in West Haven Yale Multiphasic Pain Inventory (WHYMPI) scoreBaseline, 6 weeks
The West Haven Yale Multiphasic Pain Inventory (WHYMPI) is a 52-item measure of various domains of the experience of pain, including pain interference (primary intervention outcome) and pain severity with daily functioning.